Академический Документы
Профессиональный Документы
Культура Документы
Midcap Conference
Ideation Series ‐ Key takeaways
11 October 2017
INDIA | MIDCAP | Conference Takeaways
We organised a Midcap Conference – Ideation Series on 6th October 2017 in
Vikram Suryavanshi (022 6246 4111)
Mumbai. In this day‐long event, we hosted various eminent companies and vsuryavanshi@phillipcapital.in
their representatives from diverse sectors such as consumer durables,
logistics, textiles, and specialty chemicals. Deepak Agarwal (+ 9122 6246 4112)
dagarwal@phillipcapital.in
Surya Patra (+ 9122 6246 4121)
Group meeting participants spatra@phillipcapital.in
9 Captain Polyplast
9 Chembond Chemicals
9 Gravita India
9 HPL electric Power
9 Lasa Supergenerics
9 Mirc Electrononics
9 Patel Integrated Logistics
9 PG Electroplast
9 Saregama India
9 Suditi Industries
9 Veto Switchgears and Cables
9 Vidhi Specialty
9 White Organic agro
Page | 1 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
Takeaways from group meetings
Captain Polyplast
CAPP IN EQUITY | M Cap: Rs 3.05bn
• Provides complete micro‐irrigation solutions – including HDPE pipes, drip
irrigation systems, and sprinklers.
• Manufacturing plant is at Rajkot, Gujarat, with drip‐line machinery from Israel
and the USA. Annual capacity: Drip‐line 158.5mn meters, HDPE pipes 4,000 MT.
• 13 sales offices in west and north India. Exports products to the Gulf, Africa, and
Latin America.
• Current capacity utilisation at Rajkot is ~55%. Transportation cost is 5‐7% of sales
price. Expanding presence (pan‐India) and is now registered in 13 states. Plans to
set up a new plant in Andhra Pradesh, 30‐40% of Rajkot’s capacity, at a capex of
about Rs 90mn.
• Most states provide subsidy of 70‐100% for mico‐irrigation, reducing the cost for
farmers. Micro‐irrigation leads to 28% lesser fertiliser consumption and improves
yield by 30‐40%.
• The company sees the global market in micro irrigation growing at 15‐16% to
reach almost US$ 7bn by 2021. The average all‐India penetration is just 5.5%,
which is much lesser than countries such as Israel, the US, and China. Half of the
cultivable land in India is still rain‐fed, providing high potential for micro
irrigation – the company estimates total potential at about 70mn ha compared
to the present 7.7mn ha.
• CAPP expanded its business activity into: (1) greenhouse construction, (2) agency
business started for LLDP (main raw material for pipes) from February 2017,
which it expects will save costs and generate profits, and (3) solar‐power pumps
(recently received an order for solar pumps from Himachal Pradesh).
Chembond Chemicals
CBC IN EQUITY | M Cap: Rs 3.05bn
• Family‐owned and professionally managed specialty chemical company
• Manufactures specialty chemicals for water treatment, polymers, construction
chemicals, high‐performance coatings, animal nutrition, and industrial biotech
products.
• Revenue is largely domestic. Amongst the leading players in the domestic water
treatment chemicals market, with 10‐12% market share. This industry is highly
fragmented with about half of the market dominated by small unorganised
players.
Key takeaways
• CBC is the second‐largest player in water treatment technologies (40% of sales)
in India. Its competitors are Nalco Water (now Ecolab), Thermax, Ion Exchange,
Vishnu Chemicals, and GE Water treatment (now Suez).
• Under water treatment, Chembond provides: (1) treatment chemicals, (2)
equipment and service, and (3) bio‐remediation.
• Sees the water‐treatment market growing at 7‐8% over the next few years and it
believes it will grow at a higher 10‐12% because of increasing demand from its
end‐user industries.
• In construction chemicals (8% of sales), CBC manufactures a wide range of
products for applications in concrete modification, waterproofing, repair, and
rehabilitation of structures and products such as admixtures for concrete and
sealants. It is a relatively small player in this segment, and is unable to see stable
growth due to intense competition.
Page | 2 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
• In animal nutrition (6% of sales) it manufactures and supplies high‐quality
enzymes, probiotics, and other products for the poultry and dairy industry. It
manufactures a range of vitamins and vitamins blends under the brand name
PreviteTM for supplementing the poultry and dairy diet. It is developing a
pipeline of products in fermentation‐based vitamins.
• Focusing on expanding its products range in polymers and adhesives.
• Plans to grow its B2C business (15% of sales) by developing a pan‐India
distribution network.
• Leading refineries and fertiliser companies are its top clients (giving repeat
business).
• Looking for inorganic growth opportunities (M&As or JVs) in its existing business
line.
• Sees no major capex over the next few years (capex at 5% of gross block).
• Expects margin to improve gradually with 15‐17% sales growth.
• Going ahead, CBC will focus on exploring export markets – such as South Africa,
MENA, and other Asian countries – for better profitability.
• CBC had an agreement with Henkel Adhesives India for toll business (pre‐
treatment chemical products for metal pre‐treatment, water treatment,
protective coatings, building chemicals, and monitoring instrumentation). In
FY16, Chembond divested 49% stake in the JV, in line with its strategy to invest in
and grow its water treatment, construction chemicals, industrial and high‐
performance coatings, animal nutrition, and industrial enzymes businesses. CBC
does not see significant impact on its operating performance due to the
divestment, as Chembond Surface Technologies was a low‐margin business.
Gravita India
GRAV IN EQUITY | M Cap: Rs 11.4bn
• Three sources of revenues — lead operations (84% of revenue), aluminium and
plastic products (10% of revenue) and turnkey operations (6% of revenue).
• It is one of the largest lead recyclers in India, with 120,000 MT of capacity across
five locations in India and another four overseas. It expects to almost double this
capacity by the end of FY19.
• Most of its plants offer logistical advantages, enabling it to maintain steady
operating profitability.
• GRAV has global access to low‐priced raw material due to a global collection
network in more than 17 countries. It imports 85% of its total RM batteries and
procures 15% locally from India.
• Sector outlook: Global lead demand was 13mn MT with a growth rate of 5%,
while Indian demand was 1.5mn MT with a growth rate of 15%.
• GRAV has recently entered into the aluminium recycling business, with a capacity
of 6,000MT, which it plans to increase to 34,800MT by FY19.
• Rising demand in the replacement market provides a worthwhile opportunity to
GRAV to ramp up its output and benefit from scale.
• Out of the total lead produced by recycling scrap, 50% goes into making
batteries, 20% goes to cable and wires companies, while 20% of sales are to
traders.
• Out of the total alloy produced, 80% goes to battery manufacturers and 20%
goes to cables and wires manufacturers.
• The contribution of lead in its business will reduce due to increasing competition.
The company expects volume growth to come from aluminium and PET.
• GRAV expects capex of Rs 1.50bn over FY18‐19 (FY18 ‐ Rs 600mn, FY19 ‐ Rs
500mn, FY20 ‐ Rs 400mn).
• Strong product mix: Expects revenue CAGR of +15% over the next 2‐3 years with
200bps margin improvement.
Page | 3 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
HPL Electric & Power
HPLE IN EQUITY | M Cap: Rs 9.8bn
• HPLE is an established electric equipment manufacturer in India; it is a market
leader in electricity energy meters (with 20% market share), on‐load changeover
switches (50% share), and the 5th largest LED manufacturer. It has 5% market
share in LV switchgears.
• A revival in pace of metering orders (after a gap of four consecutive quarters)
provides healthy revenue visibility. Currently, its order book is Rs 3bn in
metering; 27mn meters are under evaluation (tenders) by various utilities.
• Potential opportunity of Smart Meters (SM) in India (EESL has opened first
tender of 5mn smart meters). These have an average gross realisation of Rs
3,000‐5,000 per meter vs. electrical meters’ realisation of Rs 1,000.
• In meters, HPLE has four competitors – Genus (20% market share), L&T (15%),
Secure (15%), and Landis & Gears (9%).
• For its B2C/retail network, it is increasing its reach by adding more dealers in
tier‐2 and 3 cities. Its current dealer network is 2,700 (more than 20,000
retailers).
• Expects its lighting segment to see healthy demand due to favourable GST rate of
12% on LED luminaries.
• Successfully implementing channel financing for dealers, which it expects will
help reduce its debtors by Rs 650mn by FY18.
• Management expects strong revenue growth of 18% in FY18 with a margin of
13% based on healthy order book in metering, increasing retail network, and
improving product mix.
Lasa Supergenerics
LASA IN EQUITY | M Cap: Rs 3.4bn
• Lasa is a vertically integrated group spanning the entire veterinary, animal, and
human health‐care value chain from discovery‐to‐delivery — with established
credentials in research, manufacturing, and global marketing.
• It has carved a niche in backward integration. Its manufacturing process uses
catalysts. It uses basic petrochemical derivatives to develop basic organic
molecules, basic intermediates to advanced intermediates, and N‐1 to API
products.
• Lasa has state‐of the‐art R&D and QA and QC centres in Mahad and Chiplun in
the Konkan region of Maharashtra. It has Laboratories to handle polymorphic
evaluation and identifying trace‐level impurities, process development, and
scale‐up labs attached to every manufacturing unit, with HPLC laboratories for
routine‐method development.
• Expects the animal health‐care market to see growth and the biological segment
to be the fastest growing.
• Sees the Indian animal healthcare market growing by over 50% by 2020. Though
there is no published data, the Indian Federation of Animal Health Companies
(INFAH) anticipates the contribution of various categories of animal health
products as: 40% feed supplements, 17% anti‐bacterial, 15% bio‐security, 13%
anti‐parasitic, 5% hormones and biological, and 10% other categories.
• In terms of global ranking, India is currently the third‐largest API producers of the
world, just after China and Italy. However, by the end of 2020, India is likely to be
the second‐largest producer after China.
• Its working capital cycle is 30 days, which it aims to turn negative. It is looking for
a JV opportunity in API, and for an acquisition in its formulation business. LASA’s
EBITDA is higher than its peers because of the catalyst process. Exports account
for 40% of revenue. Its current debt is Rs 350mn and it has an ambitious growth
target of 20‐25% revenue CAGR.
Page | 4 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
Mirc Electronics
MIRC IN EQUITY | M Cap: Rs 7.2bn
• Leading manufacturer of television sets – has transformed into a complete
consumer‐durables company. Wide product portfolio includes television, air
conditioners, washing machines, microwave ovens, and mobile phones.
• Air conditioners (46% of revenue): Roughly 7% market share in split ACs. With
innovative products, low penetration, increasing affordability, and better
availability of electricity, the AC market is poised to see strong growth over the
next couple of years.
• Televisions (39% of revenue): About 4% market share in television; intends to
increase this to about 8% in the next two years. Lower penetration (currently at
only 50%) and launches of new products leave ample room for accelerated
growth.
• Washing machines (9% of revenue): Industry size is 5mn units. Expects this to
grow by 10‐12% over the next 2‐3 years (huge untapped rural market). Currently,
it has a market share of approximately 2%. Expects to capture 6% market share
in this segment over the next two years with new product launches (planning to
launch 15 new products over the next year), full operations at its Rourkee
facility, and increasing penetration in the rural market.
• MIRC has a strong dealer network of 4,000. It plans to increase its dealer
network to 6,000 over 2‐3 years.
• Currently 30% of revenue comes from rural areas and 70% from urban. It is
aggressively increasing its presence in rural areas and expects it to contribute
50% of revenue.
• ONIDA is a leading brand in televisions (#4). MICR will increase its advertisement
spend to 3% of sales by the end of FY18.
• Display devices: Manufacturing plant located at Wada near Mumbai, spread
across 55 acres. Has a capacity of 1.8mn display devices, which can be scaled up
to 3mn at a minimal capex.
• Rourkee facility: Can assemble 240,000 washing machines per annum on a single
shift, which can be scaled up to 720,000 pieces on three shifts.
• Strong product mix and revival of high‐margin products (washing machines) will
result in a 250bps margin improvement over the next two years.
• Focused on reducing debt by selling non‐core assets. Its current debt is Rs 1.2bn
and it has non‐core assets of more than 1.5bn. Expects to become debt‐free over
the next year.
Patel Integrated
PTIL IN EQUITY | M Cap: Rs 1.3bn
• It has two major business segments: (1) air‐cargo transport (~60%), and (2) road
transport (40%). It is a leading air‐cargo consolidator, with an asset‐light model.
In road transport, it provide less‐than‐truck‐load (LTL), door‐to‐door express
cargo, and full‐truck‐load (FTL) services.
• It is expanding its distribution network to pan‐India from current 500+ branches.
After GST, the management is hopeful that warehouses and logistics outsourcing
will consolidate. It has acquired land for a warehouse at Bangalore and is looking
at expanding warehouses at Ahmedabad, Chennai, Hyderabad, the NCR region,
and other strategic locations.
• After GST, it has been unable to calculate any reduction in truck travel time
because of poor road conditions in monsoons and lower cargo demand.
• Management believes that the e‐way bill (with validity condition of 24 hours up
to 100km) is not useful and should be removed. Under GST, transporters need to
carry an electronic waybill while moving goods.
• The government has allowed transporters to use either 5% GST without input
credit or 12% with input credit – the company has opted for 12%.
Page | 5 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
PG Electroplast
PGEL IN EQUITY | M Cap: Rs 6.9bn
• PGEL manufactures and assembles a range of consumer electronic components
and finished products such as colour televisions (CTVs) and components, air
conditioners (ACs), lighting (ELD and CFL), and mobile phones for leading brands.
• As backward integration, PGEL also does plastic injection moulding and
manufactures printed circuit boards (PCB) assemblies for CTVs, CFLs, and ELDs.
• It has three business verticals: (1) plastic moulding, (2) EMS (electronic
manufacturing services), and (3) ODM (original design manufacturer).
• In plastic moulding, it caters to consumer durables, automobiles, and sanitary‐
ware companies.
• Segment‐wise margins: Plastic moulding 9%, EMS 3%, ODM 22%.
• One of the largest suppliers for LG, which currently contributes to 40% of PGEL’s
revenue vs. 90% three years ago.
• Aggressively increasing its product offering and adding new customers to
diversify its product profile.
• Capacity to produce 2mn LED TVs and 0.5mn AIRCON printed circuit boards.
• Started assembling mobile phones for brands such as Lava, Intex, and others.
• Capex plan: FY18 ‐ Rs 400mn, FY19 ‐ Rs 500mn, and FY20 ‐ Rs 500mn.
• Increasing customer base and products mix; expects revenue CAGR of 20% over
the next 2‐3 years.
Saregama
SARE IN EQUITY | M Cap: Rs 940mn
Saregama is a leading Indian entertainment content company with a music library of
120,000 songs and 3,000 hours of television content. Key takeaways of the
conference meetings are as follows:
• Its long‐term strategy is clearly to be a content‐IP company. It sees immense
growth in content consumption and demand, which will be a key revenue driver.
It has dabbled in other aspects such as services, but now firmly believes that a
long‐term viable strategy is content IP. Its strategy focuses on content
production, acquisition (IP rights), and content monetisation (existing and new).
• Content monetisation currently contributes to 65% of its revenues, and includes
music rights and publishing. The share of physical music content (CDs, tapes) has
been consistently declining while online has been consistently increasing with
the rise of OTT platforms.
• Revenue from telecom service producers has been declining as the number of
players has shrunk. This stream will continue to be under pressure, but SARE is
now operating with only a few strong players to avoid problems of receivables.
• To further content monetisation, SARE has launched a portable music player
Carvaan with a song library of 5,000 greatest hits. It has also launched Carvaan
Mini for the younger audience. We believe the company has already sold
100,000 Carvaan units, demand for the product is robust, and that Carvaan Mini
is likely to sell 50,000 units.
• SARE has not acquired any major music rights in the last 10 years, but has now
started with small‐ticket acquisition and will continue this strategy for now, as
big movies are very expensive and monetisation challenges are significant.
• The TV content production business was making losses for a while, but SARE
managed to turn around this business in FY17. However, this is not going to be a
key focus area for the company, unless it owns a copyright of the content (which
it does in case of production for SUN TV).
Page | 6 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
• Apart from these streams, Saregama is producing small‐ticket movies with a
focus on content meant for personalised viewing on platforms such as Netflix
and Amazon Prime – from where demand for content is huge.
• Overall, the company has carved out a clear‐cut strategy. In the medium term,
Carvaan will drive its revenue growth, but in the long‐term, success of new
content and monetisation of its existing content online will drive growth. SARE’s
CEO, Mr Vikram Mehra, provides a much needed fresh outlook for the company
in terms of establishing best practices and providing a long‐term strategic growth
vision (he has significant experience with Tata Sky).
Suditi Industries
SDHP IN EQUITY | M Cap: Rs 1.2bn
• Suditi is a reputed quality manufacturer of hosiery fabrics and garments for many
established brands. It is a vertically integrated textile‐ and apparel‐manufacturing
house with processes such as knitting, dyeing, printing, finishing, and
garmenting.
• Its key clients in retail are EBOs (exclusive brand outlets) and large‐format stores
such as Central, Shoppers Stop, Pantaloons, Lifestyle, Walmart, and e‐commerce
companies such as Jabong, Myntra, Amazon, Flipkart, and Snapdeal. Its retail
businesses include:
o Licensed brands: FC Barcelona, Manchester City FC, MTV, YouWeCan (with
cricketer Yuvraj Singh)
o Own brands: Riot and Indianink.
• Its fabric and garments businesses supply to big retailers such as Madura Group,
Reliance, Creative Garments, Gini & Jony, Choudhary Garments, Future Group,
Mandhana Industries, Myntra Designs, Siyaram Silk Mill, Shoppers Stop,
Raymond, Lee Cooper, Walmart, and Burnt Umber.
• Licensed brands and tie‐ups with celebrities gives it access to space at all retail
large platforms. It also saves time and money in creating and establishing brands.
It recently announced a JV (50:50) with Bollywood star Anushka Sharma for a
fashion line for denims, jackets, and dresses. The company expects strong
traction from this brand over 2‐3 years.
Veto Switchgears and Cables
VSCL IN EQUITY | M Cap: Rs 4bn
• Currently VSCL has a strong presence in Rajasthan with 2,200 dealers. Its total
dealer network is 3,000 dealers. It is expanding presence outside Rajasthan to
drive domestic revenue.
• Rajasthan contributes to 70% of sales (FY17 revenue: Rs 850mn), Gujarat
contributes to 8% (Rs 100mn, entered in 2013), and NCR (Rs 50mn) 4%.
• Expanding its presence in other states though B2C channels (focusing more on
tier‐2 cities).
• Management expects EBITDA margin of 14%, despite high dealer margin of 6%
(vs. competitors’ 3%), as it expects to benefit from better operating leverage and
improvement in utilisation. Currently, its plants are running at a utilisation of
33%/16% on single / double shifts.
• Its prices of switchgears / cables are 10% / 7% below its competitor (Anchor).
• It is setting up a new LED assembly plant in Vasai, Maharashtra, with a capex of
Rs 25mn; likely turnover of Rs 300mn. This will help to shift its domestic and
Dubai requirements of LEDs to domestic manufacturing vs. its earlier sourcing
from China.
• It has set up a wire & cables manufacturing plant in Mahindra SEZ, Rajasthan, at
a capex of Rs 40mn, which will help to replace 50% of its sourcing from China.
Page | 7 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
• Working capital to reduce: Management highlighted improvement in standalone
working capital led by change in sales mix – from a high working‐capital cycle
B2C business in Rajasthan and Gujarat (receivables 100 days) to B2C business in
other states (30 days). Its Dubai business has a working‐capital cycle of 90 days
with sales from Africa on receipt of advance.
Vidhi Speciality Food Ingredients
VSFI IN EQUITY | M Cap: Rs 3.7bn
About the company
VSFI is the third‐largest manufacturer of synthetic food‐grade colours globally. It is
among the very few USFDA‐approved manufacturers of food‐grade colours in India. It
makes edible food colours for various industries including pharmaceuticals,
confectionery, pet foods, healthcare, dairy, soft drinks, and cosmetics.
Key takeaways
• VSFI has a complete product portfolio in synthetic food colours with USFDA /
European Commission / JECFA approvals.
• Strong relationships with clients are a sound entry barrier. Its major clients
include global majors such as Nestle, Mars, and Sanofi.
• It has established distributors / sole selling agents and stockists in over 50
countries across six continents. Exports constitute 98% of its manufacturing
revenue.
• Europe is its largest market, contributing 40% of revenue, followed by North
America, Australasia, and South America.
• VSFI imports a batch size of raw materials, which its current capacities cannot
fully utilise. It sells unused raw materials to other industries, which is reflected in
trading revenue.
• Company is working on introduction of few colours in C&D with minimal global
competition.
• Industry highlights:
o As per industry estimates, the global natural and synthetic food colour
market CAGR is likely to be 4.5% – to reach US$ 2.5bn by 2020.
o There are only four major players: Sensient Technologies (20,000 MT), Roha
Dyechem (9,000 MT), VSFI (3,600 MT), and ITC Colour.
White Organic Agro
WDI IN EQUITY | M Cap: Rs 1.3bn
• It was originally a diamond‐trading company; stepped into organic farming in
September 2016. It has its own sourcing and processing unit for organic
products. It has started its retail business.
• White organics has leased land of 530 acres for own farming, which accounts for
30% of its revenue. Trading via subsidiary Future Farms contributes 70% of
revenue.
• The company has 530 farmers registered with 2,800 acres of land for organic
cultivation. The company is expanding its own lease operation through the
acquisition of 90% stake in Future Farms LLP, Rajkot, which has 600 acres under
organic manufacturing. Its farming business is mainly in Gujarat.
• Six retail stores are operational in Mumbai, Surat, Baroda, Morbi, and Anand,
which offer more than 300 pure organic foods. In the first phase of expansion,
WDI is looking at 50 retail stores in Maharashtra and Gujarat.
• It believes ecommerce is a high‐potential way of increasing sales and
awareness. It recently launched a fully integrated commerce online gateway
www.whiteorganics.co.in and plans to launch a mobile application soon. It has
franchise pickup points and an option for home delivery.
Page | 8 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
• WDI sells its products under the brand name White Organics. It focuses on brand
creation and will approach larger retailers (such as Big Bazaar) in the future.
• The Joint Commissioner, Food and Medical Control department, has granted it a
manufacturing license for various organic medicinal and nutritional products
(ayurvedic and herbal tablets, capsules, churna for oral consumption, few
cosmetics).
• It has an entire organic product range (200 premium organic products in 12
major categories and 17 sub‐categories). It is operating in the domestic market
currently, but will focus on exports from FY19 after completing three years for
certification. Realization and margins are substantially higher in export. It
estimates its export: import mix at 60:40 over the next five years.
Page | 9 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
Management
Vineet Bhatnagar (Managing Director) (91 22) 2483 1919
Kinshuk Bharti Tiwari (Head – Institutional Equity) (91 22) 6246 4101
Jignesh Shah (Head – Equity Derivatives) (91 22) 6667 9735
Research
Automobiles Engineering, Capital Goods Pharma & Specialty Chem
Dhawal Doshi (9122) 6246 4128 Jonas Bhutta (9122) 6246 4119 Surya Patra (9122) 6246 4121
Nitesh Sharma, CFA (9122) 6246 4126 Vikram Rawat (9122) 6246 4120 Mehul Sheth (9122) 6246 4123
Banking, NBFCs IT Services & Infrastructure Strategy
Manish Agarwalla (9122) 6246 4125 Vibhor Singhal (9122) 6246 4109 Naveen Kulkarni, CFA, FRM (9122) 6246 4122
Pradeep Agrawal (9122) 6246 4113 Shyamal Dhruve (9122) 6246 4110 Neeraj Chadawar (9122) 6246 4116
Paresh Jain (9122) 6246 4114 Logistics, Transportation & Midcap Telecom
Consumer & Retail Vikram Suryavanshi (9122) 6246 4111 Naveen Kulkarni, CFA, FRM (9122) 6246 4122
Naveen Kulkarni, CFA, FRM (9122) 6246 4122 Media
Preeyam Tolia (9122) 6246 4129 Naveen Kulkarni, CFA, FRM (9122) 6246 4122 Technicals
Metals Subodh Gupta, CMT (9122) 6246 4136
Cement Dhawal Doshi (9122) 6246 4128 Production Manager
Vaibhav Agarwal (9122) 6246 4124 Ganesh Deorukhkar (9122) 6667 9966
Economics Mid-Caps Editor
Anjali Verma (9122) 6246 4115 Deepak Agarwal (9122) 6246 4112 Roshan Sony 98199 72726
Shruti Bajpai (9122) 6246 4135 Oil & Gas Sr. Manager – Equities Support
Sabri Hazarika (9122) 6246 4130 Rosie Ferns (9122) 6667 9971
Page | 10 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
Disclosures and Disclaimers
PhillipCapital (India) Pvt. Ltd. has three independent equity research groups: Institutional Equities, Institutional Equity Derivatives, and Private Client Group.
This report has been prepared by Institutional Equities Group. The views and opinions expressed in this document may, may not match, or may be contrary at
times with the views, estimates, rating, and target price of the other equity research groups of PhillipCapital (India) Pvt. Ltd.
This report is issued by PhillipCapital (India) Pvt. Ltd., which is regulated by the SEBI. PhillipCapital (India) Pvt. Ltd. is a subsidiary of Phillip (Mauritius) Pvt. Ltd.
References to "PCIPL" in this report shall mean PhillipCapital (India) Pvt. Ltd unless otherwise stated. This report is prepared and distributed by PCIPL for
information purposes only, and neither the information contained herein, nor any opinion expressed should be construed or deemed to be construed as
solicitation or as offering advice for the purposes of the purchase or sale of any security, investment, or derivatives. The information and opinions contained in
the report were considered by PCIPL to be valid when published. The report also contains information provided to PCIPL by third parties. The source of such
information will usually be disclosed in the report. Whilst PCIPL has taken all reasonable steps to ensure that this information is correct, PCIPL does not offer
any warranty as to the accuracy or completeness of such information. Any person placing reliance on the report to undertake trading does so entirely at his or
her own risk and PCIPL does not accept any liability as a result. Securities and Derivatives markets may be subject to rapid and unexpected price movements
and past performance is not necessarily an indication of future performance.
This report does not regard the specific investment objectives, financial situation, and the particular needs of any specific person who may receive this report.
Investors must undertake independent analysis with their own legal, tax, and financial advisors and reach their own conclusions regarding the appropriateness
of investing in any securities or investment strategies discussed or recommended in this report and should understand that statements regarding future
prospects may not be realised. Under no circumstances can it be used or considered as an offer to sell or as a solicitation of any offer to buy or sell the
securities mentioned within it. The information contained in the research reports may have been taken from trade and statistical services and other sources,
which PCIL believe is reliable. PhillipCapital (India) Pvt. Ltd. or any of its group/associate/affiliate companies do not guarantee that such information is accurate
or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice.
Important: These disclosures and disclaimers must be read in conjunction with the research report of which it forms part. Receipt and use of the research
report is subject to all aspects of these disclosures and disclaimers. Additional information about the issuers and securities discussed in this research report is
available on request.
Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the
research analyst’s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the
research analyst’s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report.
Additional Disclosures of Interest:
Unless specifically mentioned in Point No. 9 below:
1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in
this report.
2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the
company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report.
3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this
research report.
4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for
any other products or services from the company(ies) covered in this report, in the past twelve months.
5. The Research Analyst, PCIL or its associates have not managed or co‐managed in the previous twelve months, a private or public offering of securities for
the company (ies) covered in this report.
6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in
connection with the research report.
7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report.
8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report.
9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report:
Sr. no. Particulars Yes/No
1 Whether compensation has been received from the company(ies) covered in the Research report in the past 12 months for No
investment banking transaction by PCIL
2 Whether Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively hold more than 1% of No
the company(ies) covered in the Research report
3 Whether compensation has been received by PCIL or its associates from the company(ies) covered in the Research report No
4 PCIL or its affiliates have managed or co‐managed in the previous twelve months a private or public offering of securities for the No
company(ies) covered in the Research report
5 Research Analyst, his associate, PCIL or its associates have received compensation for investment banking or merchant banking or No
brokerage services or for any other products or services from the company(ies) covered in the Research report, in the last twelve
months
Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment
banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek
compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the
securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any
of the securities covered in the report.
Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or
particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors.
Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and
accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The
value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or
political factors. Past performance is not necessarily indicative of future performance or results.
Page | 11 | PHILLIPCAPITAL INDIA RESEARCH
MIDCAP CONFEERENCE KEY TAKEAWAYS
Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be
reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not
be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice.
Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its
affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind
including but not limited to any direct or consequential loss or damage, however arising, from the use of this document.
Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No
reprinting or reproduction, in whole or in part, is permitted without the PCIPL’s prior consent, except that a recipient may reprint it for internal circulation only
and only if it is reprinted in its entirety.
Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are
subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether
trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of
its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that
trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside
PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or
profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of
PhillipCapital’s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole
responsibility. You must also read the Risk Disclosure Document and Do’s and Don’ts before investing.
Kindly note that past performance is not necessarily a guide to future performance.
For Detailed Disclaimer: Please visit our website www.phillipcapital.in
For U.S. persons only: This research report is a product of PhillipCapital (India) Pvt Ltd., which is the employer of the research analyst(s) who has prepared the
research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any
U.S.‐regulated broker‐dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker‐dealer, and is/are not required to satisfy the
regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with
a subject company, public appearances, and trading securities held by a research analyst account.
This report is intended for distribution by PhillipCapital (India) Pvt Ltd. only to "Major Institutional Investors" as defined by Rule 15a‐6(b)(4) of the U.S.
Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by the U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a
6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the
sender. Further, this report may not be copied, duplicated, and/or transmitted onward to any U.S. person, which is not a Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a‐6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain
business with Major Institutional Investors, PhillipCapital (India) Pvt Ltd. has entered into an agreement with a U.S. registered broker‐dealer, Decker & Co, LLC.
Transactions in securities discussed in this research report should be effected through Decker & Co, LLC or another U.S. registered broker dealer.
If Distribution is to Australian Investors
This report is produced by PhillipCapital (India) Pvt Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services Licence No.
246827).
This report contains general securities advice and does not take into account your personal objectives, situation and needs. Please read the Disclosures and
Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with
these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced,
distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the
sender immediately.
PhillipCapital (India) Pvt. Ltd.
Registered office: No. 1, 18th Floor, Urmi Estate, 95 Ganpatrao Kadam Marg, Lower Parel West, Mumbai 400013
Vikram Vilas
2.5.4.20=05b3477dbcbe37348e8f28e3d6a0c12da34
3db31e5ec7bfb8f3420bbd40b5b12,
postalCode=421202, st=Maharashtra,
2.5.4.45=0341006232376635393464323462333466
Suryavanshi
313836376533353463623437613736386163393339
346631386337663266626263303430383832366632
3064633333623665,
serialNumber=eb1164cde1b22a71dddeeaf58164a7
2cdc84d4d9f522eff6df41efb8603abf1a, cn=Vikram
Vilas Suryavanshi
Date: 2017.10.11 09:52:59 +05'30'
Page | 12 | PHILLIPCAPITAL INDIA RESEARCH